Home
Storia in 4 fonti
Sales of Novo Nordisk’s diabetes drugs including Ozempic slow sharply
Fierce competition and threat of Trump tariffs lead to Danish company cutting costs
- ·
cincodias.elpais.com
Novo Nordisk, de reinar en solitario con sus fármacos contra la obesidad a dilapidar sin freno su valor en Bolsa
La acción se derrumba un 70% desde máximos de hace un año, evaporando 430.000 millones en capitalización. La falta de reflejos ante la dura competencia y la amenaza de aranceles…
- ·
theguardian.com
Sales of Novo Nordisk’s diabetes drugs including Ozempic slow sharply
Fierce competition and threat of Trump tariffs lead to Danish company cutting costs
- ·
telegraph.co.uk
The amazing rise and shocking fall of the company that created Ozempic
A string of blunders led to the value of Novo Nordisk dropping £52bn last week. Could a new weight-loss pill help it regain its crown?
- ·
nytimes.com
How Ozempic Maker Novo Nordisk Lost Its Shine
The pioneering Danish drugmaker was once the most valuable company in Europe, but analysts say a number of missteps reversed its fortunes.